DWIGHT SMITH: Open Payments
NPI 1831309020 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,061 in 92 payments from 14 companies in 2025. Trend: 2023 $1,998 · 2024 $2,830 · 2025 $2,061
Food & beverage: $2,061
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 15 | $385 |
| ABBVIE INC. | 19 | $383 |
| E.R. Squibb & Sons, L.L.C. | 13 | $304 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $238 |
| Vanda Pharmaceuticals Inc. | 7 | $197 |
| Alkermes, Inc. | 10 | $181 |
| Corium, LLC | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Janssen Pharmaceuticals, Inc | 2 | $57 |
| Lundbeck LLC | 2 | $45 |
Products named: SUBLOCADE, VRAYLAR, COBENFY, CAPLYTA, FANAPT, ARISTADA, REXULTI, Azstarys.
Industry payments across MA — which companies pay providers there.
